Avacta Group plc (LON:AVCT) CEO Alastair Smith joins DirectorsTalk to discuss first clinical evaluation of lateral flow antigen test. Alastair talks us through the data and explains the next steps in taking the test to market.
Avacta in talks to establish route to market for COVID-19 test
Yorkshire-based Avacta is in talks to establish the route to market for a COVID-19 test that can be deployed in hospitals in the UK and Europe. Avacta Group has announced significant progress in the development of